Current investments

Receive information about current investment opportunities

Sign in or create an account to receive information about current share issues.

Completed investments

Single Technologies

The company has developed a DNA sequencing solution with significantly improved performance compared with current alternatives. The market is growing rapidly in terms of both research and clinical applications.

Read more

Likvor

Likvor offers a CE-certified system helping healthcare personnel to diagnose normal pressure hydrocephalus (NPH) which is a very under diagnosed condition with dementia-like symptoms.

Read more

EMPE Diagnostics

Each year, more than 10 million people suffer from tuberculosis. EMPE has developed a patented quick test for the diagnosis of tuberculosis adapted to clinics with limited resources.

Read more
Sciety_financed_companies_1928_diagnostics

1928 Diagnostics

1928 Diagnostics is fighting against the global threat of resistant bacteria by offering software for the quick and effective diagnose of bacterial infections. The software is offered as a software-as-a-service and in combination with hardware already used in hospitals it provided detailed information regarding bacteria and their resistance profiles.

Read more

Exits

Lipigon Pharmaceuticals

Lipigon develops orphan drugs for illnesses due to disorders in how the body handles fat. The company’s major program, Lipsense, focuses on the illness, HoFH, where there is, today, no sufficient treatment.

Read more
Sciety_Cartana_NeuroKits

Cartana

Cartana’s patent-applied research tool revolutionizes the possibility of analyzing tissue samples, providing pharmaceutical companies with important information in their quest for new treatments.

Read more

Inhalation Sciences

Inhalation Science’s technology is used by leading players in the chemical and pharmaceutical sectors to study how airborne particles affect the human body.

Read more

Attana

With Attana’s patented technology, pharmaceutical companies can evaluate, in an early development stage, how drug candidates impact the body and can identify the risk of side effects.

Read more